Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging US$ 25.82 ★★★★★ 4.4 (21 reviews)
Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes US$ 21.61 ★★★★★ 5.0 (10 reviews)
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells US$ 27.35 ★★★★★ 4.0 (5 reviews)
foxo4-dri peptide senolytic human trial Molecular modelling of the FOXO4-TP53 interaction to design senolytic US$ 21.80 ★★★★★ 4.7 (16 reviews)
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI US$ 26.19 ★★★★★ 4.4 (28 reviews)
foxo4-dri peptide senolytic human trial Development of a novel senolytic by precise disruption of FOXO4 US$ 29.30 ★★★★★ 5.0 (6 reviews)
Development of a novel senolytic by precise disruption of FOXO4-p53 complex US$ 21.67 ★★★★★ 4.4 (14 reviews)
FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice US$ 20.52 ★★★★★ 4.0 (6 reviews)
PDF) Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes US$ 23.01 ★★★★★ 4.4 (25 reviews)
Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis US$ 23.74 ★★★★★ 4.0 (19 reviews)
Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis US$ 29.70 ★★★★★ 4.0 (8 reviews)
FOXO4-DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) US$ 25.93 ★★★★★ 4.2 (28 reviews)
FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway US$ 28.02 ★★★★★ 5.0 (21 reviews)
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging US$ 26.41 Min. order: 1 piece ★★★★★ 4.8 (21 reviews) Sold : Login>>
how often to take cagrilintide Cagrilintide 10mg Long-Acting Amylin Analog US$ 28.85 Min. order: 1 piece ★★★★★ 4.7 (20 reviews) Sold : Login>>
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 24.14 Min. order: 1 piece ★★★★★ 4.9 (11 reviews) Sold : Login>>
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 22.95 Min. order: 1 piece ★★★★★ 4.0 (14 reviews) Sold : Login>>